Alpna Seth
At a glance: Alpna Seth is Director at Keros Therapeutics (KROS). Their latest SEC Form 4, filed Jun 5, 2026, reported a sale of $28K. On file: 0 purchase lines ($0) and 1 sale line ($28K).
Disclosed holdings: about $116K of KROS stock: 9,767 shares reported on their latest Form 4 (filed Jun 5, 2026), valued at the Nov 19, 2026 close of $11.85. This counts only KROS shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Keros Therapeutics, Inc. (KROS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 5SEC | KROSKeros Therapeutics, Inc. | Sell Plan | 2,6259,767 held (−21%) | $10.72 | $28K | +10.5% |
- Sell
Director Alpna Seth sold $28K of KROS at $10.72 — pre-scheduled 10b5-1 plan sale.
Follow Alpna Seth
Get one email when Alpna Seth files a new purchase or sale. Free.
At most one email a day about Alpna Seth, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.